Medically reviewed by a board-certified gastrointestinal oncologist. Last reviewed: June 2026.

If you or someone in your family has been diagnosed with colorectal cancer in Nigeria, finding a local specialist can be difficult. Waiting times at many oncology centers last for weeks. Biomarker tests - lab panels that show which treatments will work for your specific tumor - are not consistently available across the country. The full range of minimally invasive surgical techniques is limited to a small number of facilities.

Many Nigerian patients seek colorectal cancer specialist care in India. Treatment costs are much lower than private care in the UK or the US. The medical visa process typically takes less than a week. The country has accredited cancer hospitals that offer various colorectal cancer treatment options.

This guide covers what you need to know before you start planning: realistic cost ranges, the visa steps, what records to bring, and how specialist care at a major Indian oncology center compares to what may be available locally.

Why Nigerian patients are choosing India for colorectal cancer care

Colorectal cancer is rising faster in sub-Saharan Africa than in almost any other region in the world. A study published in PLOS ONE (2024) found that around 70,428 new colorectal cancer cases were recorded across Africa in 2022. That number is projected to climb by nearly 140 percent by 2050.

In Nigeria specifically, the five-year survival rate after a colorectal cancer diagnosis is approximately 22 percent, according to research from the African Research Group for Oncology (2024). In the United States, the five-year survival rate for the same diagnosis is around 65 percent. That gap does not mainly reflect biology. It reflects gaps in access to timely, specialist-led care - including biomarker testing, complete surgical teams, and combination treatment approaches.

Three factors most often drive Nigerian patients toward specialist care in India:

• Biomarker testing. Modern colorectal cancer treatment depends on knowing your tumor's genetic profile. Tests for KRAS, NRAS, and BRAF gene mutations - and for microsatellite instability (MSI) status - are part of standard care guidelines from bodies such as the American Cancer Society. These results directly affect which treatments your oncologist can recommend. Access to reliable, timely biomarker testing is a significant gap in many parts of Nigeria.
• Minimally invasive surgery. Laparoscopic and robotic-assisted colorectal surgery - keyhole approaches that reduce recovery time and complication risk compared to open surgery - are routine at major Indian cancer hospitals. Access to these techniques in Nigeria is limited to a small number of private facilities.
• Cost. Even when travel and accommodation costs are included, colorectal cancer treatment in India is often much more affordable than private specialist care in the UK, United States, or Gulf states. For many families paying out of pocket, that difference makes specialist care abroad a realistic option.

How do colorectal cancer treatment costs and access compare between India and Nigeria?

India cost figures sourced from Medsurge India and Hospisity (2025 estimates for international patients; medical tourism planning services). Nigeria private-sector cost data is not consistently published - request a written quote from your treating hospital before making any comparison. All figures in USD. Exchange rates change; confirm costs at the time of booking.

India's treatment costs are typically 60 to 80 percent lower than comparable private care in the UK or the US. This remains true even before accounting for better access to biomarker testing and surgical techniques. For many Nigerian families paying out of pocket, specialist care abroad becomes affordable when flights and accommodation costs are included.

The medical visa process for Nigerian patients - step by step

The Indian government issues a special Medical Visa (MED) for patients traveling for treatment, and a Medical Attendant Visa (MED-X) for up to two family members or caregivers. The process for Nigerian applicants is well established. According to the High Commission of India in Abuja, here is how it works:

Step 1: Contact the Indian hospital first. Before applying for a visa, reach out to the international patient services office at your chosen hospital. They will review your records, provide a treatment plan and cost estimate, and issue an official appointment letter on hospital letterhead. This letter is the key document for your visa application.

Step 2: Get a referral letter from your Nigerian doctor. Your local oncologist or general practitioner writes a letter describing your diagnosis and explaining why treatment in India is needed. This is a supporting document for the visa - it does not commit you to any specific hospital or treatment path.

Step 3: Prepare your full document set. The High Commission requires:

• A Nigerian passport valid for at least six months beyond your planned arrival date in India
• The appointment letter from the Indian hospital
• Your referral letter from a Nigerian doctor
• Copies of your medical reports, scan results, biopsy report, and recent lab tests
• Proof of funds sufficient to cover treatment and living costs during your stay
• A Yellow Fever vaccination certificate - the vaccine must be given at least 10 days before travel
• A Polio (OPV) vaccination certificate - administered at least four weeks before travel
• Two recent passport-size photographs

Step 4: Apply at the High Commission or online. You can apply in person at the High Commission of India in Abuja or the Indian Consulate in Lagos. An e-Medical visa option is available online and typically processes in two to five working days. Standard in-person applications take three to five working days.

Step 5: Arrange your attendant visa. If a family member or caregiver is traveling with you, they apply for a MED-X visa at the same time, using the same hospital appointment letter. Up to two attendants are permitted per patient.

A Medical Visa is typically granted for 60 to 90 days. If your treatment extends beyond that period, it can usually be extended through the Foreigners Regional Registration Office (FRRO) at your location in India.

What to bring and how to prepare before you travel

The most common reason treatment gets delayed on arrival in India is incomplete or missing medical records. Before you leave Nigeria, gather the following:

• The full pathology report from your biopsy - not just a summary, but the complete written laboratory report
• CT scan, MRI, or PET-CT imaging on a CD or as a digital file the Indian hospital can access
• A colonoscopy report, if you have had one
• Records of any treatment already started, including chemotherapy cycle notes, radiation plans, or operative summaries
• Blood test results from the past three months
• A written list of all current medications and dosages

Bring originals where possible, along with at least two sets of photocopies. Indian oncology teams review your records before your first appointment to confirm your diagnosis and disease stage. If KRAS, NRAS, BRAF, or MSI testing has not been done yet, many specialist hospitals can arrange this on arrival. Having results in advance saves time and may reduce your overall treatment cost.

Practical logistics matter too. Accommodation near major Indian cancer hospitals is widely available at various price points, and most large hospital campuses have on-site or adjacent guesthouses for international patient families. Your international patient coordinator can help arrange this as part of your initial planning process.

What specialist colorectal cancer care in India includes

Major Indian oncology hospitals - including those accredited by Joint Commission International (JCI) and India's National Accreditation Board for Hospitals and Healthcare Providers (NABH) - offer multidisciplinary cancer care. For colorectal cancer, this typically means your case is reviewed by a team that includes a surgical oncologist, a medical oncologist, a radiation oncologist, and a gastroenterologist, working together on a single coordinated treatment plan.

Biomarker testing is a standard part of the diagnostic workup at specialist Indian centers. A study from a tertiary care hospital in northern India, published in PubMed Central (2021), confirmed that MSI testing using PCR technique was performed routinely and that results carried clinical significance for treatment planning and prognosis. KRAS, NRAS, and BRAF gene testing - which helps determine eligibility for targeted therapies - is similarly standard at these hospitals.

For a plain-English breakdown of what colorectal cancer treatment decisions typically involve, including surgery, chemotherapy, targeted therapy, and how biomarker results guide each choice, see the HealthUnwired guide on colorectal cancer treatment options and why specialist input matters.

Getting an online second opinion before you book your travel

Before arranging flights and visas, many patients find it valuable to get an independent clinical review of their records. An online second opinion from a specialist oncologist may help you:

• Confirm whether the diagnosis and staging from Nigeria are accurate before committing to a treatment path
• Understand whether traveling to India for specific care - robotic surgery, biomarker-guided targeted therapy - is genuinely necessary for your situation
• Prepare specific clinical questions to bring to the Indian hospital team before your first appointment

This step can save real money. If care closer to home is clinically appropriate, you avoid unnecessary travel costs. If specialist care in India is the right call, you arrive prepared. The HealthUnwired resource on expert colorectal cancer care through an online second opinion explains what a remote specialist review covers and how to upload your records securely.

You can upload your reports, choose a verified oncologist, and book a video consultation through HealthUnwired, typically within 48 hours, without leaving Nigeria.

Remote follow-up after you return to Nigeria

Treatment at an Indian specialist center does not have to end when your visa expires. Most major hospitals have international patient departments that support remote follow-up. After you return to Nigeria, your Indian oncologist can review follow-up imaging and lab results sent electronically, adjust your oral medication plan based on response data, and communicate directly with your local doctor to coordinate continued care.

Setting up this communication pathway before you leave India is important. Ask your international patient coordinator to confirm the process for sending follow-up scans and reports remotely, and to clarify that your treating oncologist will be available for scheduled video consultations after you return home. For a practical look at how this kind of remote follow-up arrangement works, the HealthUnwired article on liver cancer treatment in India for international patients covers comparable logistics and what to ask before your departure.

When to talk to your doctor

Speak with your oncologist or care team if:

• Your current treatment plan has not included KRAS, NRAS, BRAF, or MSI biomarker testing after a colorectal cancer diagnosis
• You are finding it difficult to access the full recommended course of treatment - surgery plus systemic therapy - close to home
• You want an independent clinical review of your records before committing to international travel
• You are a caregiver managing this research and planning on behalf of a patient who cannot do it themselves

This article is for general information and is not a substitute for medical advice. Always consult your oncologist or care team about your specific situation.